Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77:1335–47. https://doi.org/10.1097/HEP.0000000000000004.

Wang S, Friedman SL. Found in translation-fibrosis in metabolic dysfunction-associated steatohepatitis (MASH). Sci Transl Med. 2023;15:eadi0759. https://doi.org/10.1126/scitranslmed.adi0759.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lonardo A, Nascimbeni F, Ballestri S, et al. Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps. Hepatology. 2019;70:1457–69. https://doi.org/10.1002/hep.30626.

Barr E, Popkin R, Roodzant E, Jaworski B, Temkin SM. Gender as a social and structural variable: research perspectives from the National Institutes of Health (NIH). Transl Behav Med. 2024;14:13–22. https://doi.org/10.1093/tbm/ibad014.

Article  PubMed  Google Scholar 

Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF, Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010;51:1972–8. https://doi.org/10.1002/hep.23527.

Summart U, Thinkhamrop B, Chamadol N, Khuntikeo N, Songthamwat M, Kim CS. Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: a population-based cross-sectional study. F1000Res. 2017;6:1630. https://doi.org/10.12688/f1000research.12417.2.

Article  PubMed  PubMed Central  Google Scholar 

Prabhakar T, Prasad M, Kumar G, et al. High prevalence of MAFLD in general population: a large cross-sectional study calls for concerted public health action. Aliment Pharmacol Ther. 2024;59:843–51. https://doi.org/10.1111/apt.17892.

Article  CAS  PubMed  Google Scholar 

Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J Hepatol. 2018;69:896–904. https://doi.org/10.1016/j.jhep.2018.05.036.

Article  PubMed  Google Scholar 

Le MH, Le DM, Baez TC, et al. Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons. J Hepatol. 2023;79:287–95. https://doi.org/10.1016/j.jhep.2023.03.040.

Article  PubMed  Google Scholar 

Park SH, Jeon WK, Kim SH, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2006;21 1 Pt 1:138–43. https://doi.org/10.1111/j.1440-1746.2005.04086.x.

Article  Google Scholar 

Polyzos SA, Goulis DG. Menopause and metabolic dysfunction-associated steatotic liver disease. Maturitas. 2024;186:108024. https://doi.org/10.1016/j.maturitas.2024.108024.

Article  CAS  PubMed  Google Scholar 

Suzuki A, Abdelmalek MF, Unalp-Arida A, et al. Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2010;8:1062–9. https://doi.org/10.1016/j.cgh.2010.08.005.

Article  PubMed  PubMed Central  Google Scholar 

Joye DAM, Evans JA. Sex differences in daily timekeeping and circadian clock circuits. Semin Cell Dev Biol. 2022;126:45–55. https://doi.org/10.1016/j.semcdb.2021.04.026.

Article  PubMed  Google Scholar 

Mukherji A, Dachraoui M, Baumert TF. Perturbation of the circadian clock and pathogenesis of NAFLD. Metabolism. 2020;111S:154337. https://doi.org/10.1016/j.metabol.2020.154337.

Article  CAS  PubMed  Google Scholar 

Son DH, Kwon YJ, Lee JH. Sex difference in skeletal muscle mass in relation to metabolic dysfunction-associated steatotic liver disease: a propensity score matching study. J Nutr Health Aging. 2024;28:100270. https://doi.org/10.1016/j.jnha.2024.100270.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, He J, Sun Q. The prevalence and effects of sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis. Clin Nutr. 2024;43:2005–16. https://doi.org/10.1016/j.clnu.2024.07.006.

Article  CAS  PubMed  Google Scholar 

DiStefano JK. NAFLD and NASH in postmenopausal women: implications for diagnosis and treatment. Endocrinology. 2020;161:bqaa134. https://doi.org/10.1210/endocr/bqaa134.

Hart-Unger S, Arao Y, Hamilton KJ, et al. Hormone signaling and fatty liver in females: analysis of estrogen receptor alpha mutant mice. Int J Obes (Lond). 2017;41:945–54. https://doi.org/10.1038/ijo.2017.50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee C, Kim J, Jung Y. Potential therapeutic application of estrogen in gender disparity of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Cells. 2019;8:1259. https://doi.org/10.3390/cells8101259.

Cherubini A, Della Torre S, Pelusi S, Valenti L. Sexual dimorphism of metabolic dysfunction-associated steatotic liver disease. Trends Mol Med. 2024;30:1126–36. https://doi.org/10.1016/j.molmed.2024.05.013.

Article  CAS  PubMed  Google Scholar 

Steiger A, VanderVeen NT, Kang EH, Weimer AK. Resolution of metabolic dysfunction-associated steatohepatitis with estradiol in a transgender female: a case report. JPGN Rep. 2024;5:223–7. https://doi.org/10.1002/jpr3.12054.

Article  PubMed  PubMed Central  Google Scholar 

Sofer Y, Osher E, Limor R, et al. Gender determines serum free cortisol: higher levels in men. Endocr Pract. 2016;22:1415–21. https://doi.org/10.4158/EP161370.OR.

Article  PubMed  Google Scholar 

Targher G, Bertolini L, Rodella S, Zoppini G, Zenari L, Falezza G. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf). 2006;64:337–41. https://doi.org/10.1111/j.1365-2265.2006.02466.x.

Article  CAS  PubMed  Google Scholar 

Charlton M, Angulo P, Chalasani N, et al. Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology. 2008;47:484–92. https://doi.org/10.1002/hep.22063.

Teixeira CJ, Veras K, de Oliveira Carvalho CR. Dehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period. J Mol Med (Berl). 2020;98:39–57. https://doi.org/10.1007/s00109-019-01842-5.

Article  PubMed  Google Scholar 

Pan J, Ding Y, Sun Y, et al. Associations between adipokines and metabolic dysfunction-associated fatty liver disease using three different diagnostic criteria. J Clin Med. 2023;12:2126. https://doi.org/10.3390/jcm12062126.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ortenzi VH, Oliveira AC, Vasconcelos RP, et al. High-fat diet elicits sex-based differences in liver inflammatory cytokines and redox homeostasis. Appl Physiol Nutr Metab. 2024;49:1083–92. https://doi.org/10.1139/apnm-2023-0457.

Article  CAS  PubMed  Google Scholar 

Hörist-Kollmann S, Strametz-Juranek J. Female dietary patterns and the pathogenesis of NAFLD. Gender and the Genome. 2018;2:49–55. https://doi.org/10.1177/2470289718787091.

Article  Google Scholar 

Merino M, Tornero-Aguilera JF, Rubio-Zarapuz A, Villanueva-Tobaldo CV, Martin-Rodriguez A, Clemente-Suarez VJ. Body perceptions and psychological well-being: a review of the impact of social media and physical measurements on self-esteem and mental health with a focus on body image satisfaction and its relationship with cultural and gender factors. Healthcare (Basel). 2024;12:1396. https://doi.org/10.3390/healthcare12141396.

Article  PubMed  Google Scholar 

Feraco A, Armani A, Amoah I, et al. Assessing gender differences in food preferences and physical activity: a population-based survey. Front Nutr. 2024;11:1348456. https://doi.org/10.3389/fnut.2024.1348456.

Article  PubMed  PubMed Central  Google Scholar 

Park WY, Yiannakou I, Petersen JM, Hoffmann U, Ma J, Long MT. Sugar-sweetened beverage, diet soda, and nonalcoholic fatty liver disease over 6 years: the Framingham heart study. Clin Gastroenterol Hepatol. 2022;20:2524–32.e2. https://doi.org/10.1016/j.cgh.2021.11.001.

Article  CAS  PubMed  Google Scholar 

Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol. 2024;29:101133. https://doi.org/10.1016/j.aohep.2023.101133.

Article  PubMed  Google Scholar 

Curci R, Bonfiglio C, Franco I, Bagnato CB, Verrelli N, Bianco A. Leisure-time physical activity in subjects with metabolic-dysfunction-associated steatotic liver disease: an all-cause mortality study. J Clin Med. 2024;13:3772. https://doi.org/10.3390/jcm13133772.

Article  CAS  PubMed  PubMed Central